Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference14 articles.
1. Soto P, Johnson-Arbor K, Fox ER, Mazer-Amirshahi M. ACMT Annual Scientific Meeting Abstracts – Virtual. Abstract 024: Drug shortages impacting agents for anticholinergic delirium. J Med Toxicol. 2022;18(2):75–125.
2. Cozanitis DA. Galanthamine hydrobromide, a longer-acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). Anaesthesist. 1977;26(12):649–50.
3. Van Kernebeek MW, Ghesquiere M, Vanderbruggen N, Verhoeven E, Hubloue I, Crunelle CL. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication. Clin Toxicol. 2021;59(5):447–8.
4. Aysın Noyan M, Elbi H, Aksu H. Donepezil for anticholinergic drug intoxication: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(5):885–7.
5. Sandia SI, Ramírez VJ, Piñero AJ, Baptista TT. Treating ‘Devil׳s Breath׳H intoxication: use of rivastigmine in six patients with toxic psychoses due to non pharmaceutical scopolamine. Eur Neuropsychopharmacol. 2017;27(8):833–4.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献